abagovomab 35
abciximab 32
abituzumab 22
abrilumab 19
actoxumab 18
adalimumab 18
aducanumab 11
afasevikumab 17
alacizumab_pegol 15
alemtuzumab 24
alirocumab 21
amatuximab 40
andecaliximab 20
anifrolumab 22
anrukinzumab 18
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 26
ascrinvacumab 7
atezolizumab 16
atinumab 15
avelumab 15
basiliximab 32
bavituximab 38
begelomab 26
benralizumab 25
bevacizumab_beta 24
bezlotoxumab 18
bimagrumab 13
bleselumab 18
blinatumomab 36
blosozumab 29
bococizumab 17
brazikumab 15
brentuximab_vedotin 28
briakinumab 16
brodalumab 13
brolucizumab 28
brontictuzumab 25
burosumab 17
cabiralizumab 25
camrelizumab 14
canakinumab 26
cantuzumab_ravtansin 46
carlumab 15
carotuximab 31
cergutuzumab_amunaleukin2 27
cergutuzumab_amunaleukin 27
certolizumab_pegol 25
cetiximab 47
citatuzumab_bogatox 27
cixutumumab 27
clivatuzumab_tetraxetan 22
codrituzumab 32
conatumumab 10
concizumab 33
crenezumab 21
crizanlizumab 25
crotedumab 21
dacetuzumab 21
daclizumab 16
dalotuzumab 37
dapirolizumab_pegol 25
daratumumab 14
dectrekumab 9
demcizumab 25
denosumab 11
depatuxizumab 22
depatuxizumab_mafodotin 22
dezamizumab 18
dinutuximab 36
diridavumab 18
domagrozumab 15
drozitumab 18
duligotuzumab 20
durvalumab 11
dusigitumab 14
efalizumab 30
efungumab 32
eldelumab 14
elezanumab 19
elgemtumab 12
elotuzumab 17
emactuzumab 19
emapalumab 25
emibetuzumab 16
enavatuzumab 24
enfortumab_vedotin 13
enoblituzumab 18
enokizumab 23
enoticumab 17
ensituximab 34
eptinezumab 18
erenumab 19
etaracizumab 18
etrolizumab 22
evinacumab 21
evolocumab 17
farletuzumab 14
fasinumab 22
fezakinumab 16
fibatuzumab 11
ficlatuzumab 22
firivumab 33
flanvotumab 18
fletikumab 24
foralumab 13
foravirumab 13
fremanezumab 29
fresolimumab 17
fulranumab 20
futuximab 30
galcanezumab 22
ganitumab 28
gantenerumab 11
gemetuzumab 27
gemtuzumab2 25
gemtuzumab 25
gevokizumab 24
girentuximab 36
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 23
ibalizumab 28
ibritumomab 32
icrucumab 9
idarucizumab 38
ifabotuzumab 11
imalumab 17
imgatuzumab 19
inclacumab 17
indatuximab_ravtansin 35
indusatumab 16
inebilizumab 30
intetumumab 14
iodine_girentuximab 29
ipilimumab 3
iratumumab 13
isatuximab 37
itolizumab 27
ixekizumab 33
labetuzumab_govitecan 25
lambrolizumab 27
lampalizumab 25
lanadelumab 18
landogrozumab 18
laprituximab 26
lebrikizumab 37
lendalizumab 22
lenzilumab 15
lifastuzumab_vedotin 25
ligelizumab 22
lilotomab 37
lirilumab 21
lodelcizumab 16
lokivetmab 26
lorvotuzumab_mertansin 28
lucatumumab 27
lumretuzumab 19
lupartumab 17
lutikizumab 21
margetuximab 35
milatuzumab 42
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 37
mogamulizumab 36
monalizumab 16
motavizumab 33
moxetumomab_pasudotox 32
namilumab 18
naratuximab 25
naratuximab_emtansin 25
narnatumab 15
navicixizumab2 30
navicixizumab 26
navivumab 36
necitumumab 10
nemolizumab 24
nesvacumab 14
nivolumab 14
obiltoxaximab 24
obinutuzumab 38
ocaratuzumab 26
ofatumumab 18
olaratumab 20
olokizumab 26
omalizumab 20
onartuzumab 22
ontuxizumab 29
opicinumab 14
orticumab 15
otelixizumab 38
oxelumab 13
ozanezumab 31
pamrevlumab 12
panobacumab 31
parsatuzumab 25
pasotuxizumab 23
pateclizumab 14
patritumab 19
pembrolizumab 27
perakizumab 22
pidilizumab 19
pinatuzumab_vedotin 19
plozalizumab 37
pogalizumab 22
polatuzumab_vedotin 22
ponezumab 39
prezalumab 14
pritoxaximab 38
quilizumab 21
racotumomab 28
radretumab 14
ralpancizumab 21
ramucirumab 14
ranevetmab 27
ranibizumab 24
refanezumab 29
remtolumab 19
rilotumumab 18
rinucumab 18
risankizumab 35
rituximab 20
rivabazumab 17
robatumumab 20
roledumab 33
romosozumab 21
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 22
sacituzumab 29
sacituzumab_govitecan 29
samalizumab 24
sapelizumab 23
sarilumab 17
secukinumab 15
seribantumab 17
setoxaximab 44
sifalimumab 11
siltuximab 27
simtuzumab 26
sirukumab 15
solanezumab 26
solitomab 31
stamulumab 20
suptavumab 22
suvizumab 20
tabalumab 14
tadocizumab 14
tamtuvetmab 33
tanezumab 21
tarextumab 11
tavolixizumab 18
telisotuzumab 26
teplizumab 21
tesidolumab 21
tezepelumab 23
tigatuzumab 17
tildrakizumab 19
timolumab 15
tisotumab 14
tosatoxumab 40
tositumomab 32
tralokinumab 27
trastuzumab 22
tregalizumab 33
trevogrumab 13
ublituximab 31
urelumab 18
ustekinumab 27
utomilumab 29
vadastuximab 24
vadastuximab_talirin 24
vandortuzumab_vedotin 16
vantictumab 21
vanucizumab2 24
vanucizumab 29
varlilumab 13
vatelizumab 21
vedolizumab 28
veltuzumab 15
vesencumab 13
vorsetuzumab 26
vorsetuzumab_mafodotin 26
vunakizumab 33
xentuzumab 18
zatuximab 37
